Congress Swing TrackerLegislative intelligence Swing vote analysis

H.R. 1262: Mikaela Naylon Give Kids a Chance Act · Congress Swing Tracker

H.R. 1262119th CongressHealth

Mikaela Naylon Give Kids a Chance Act

Sponsored by Rep. Michael T. McCaul (R-TX) · 313 active : 132 Republicans, 180 Democrats, 1 Independent

Latest action: Received in the Senate.

Read the summary

Where it standsPassed House, now in the Senate

Passed House

House: passedDec 1, 2025
Senate: next
President: not yet

9 senators score as swing votes

Summary

, via Congress.gov

Summary on Congress.gov

Give Kids a Chance Act of 2025

This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.

Specifically, the bill

modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met;

Read full summary

permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement;

renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and

reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.

The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In

Catalyst Pharmaceuticals, Inc. v. Becerra

, a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

How the projections held up

Each member’s recorded vote compared with their swing projection from before the vote. A member by voting against most of their own party.

House

Passed by voice vote or unanimous consent: no individual votes recorded.

Committees and subjects

Committees

House Committee on Energy and Commerce · HouseReported by · Markup by · Referred to

Subjects

Arab-Israeli relations
Bahrain
Cancer
Child health
Computers and information technology
Congressional oversight
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Food and Drug Administration (FDA)
Government information and archives
Government studies and investigations
Health information and medical records

Show all 23 subjects

International law and treaties

Senate · 100 House · 433

Model

v3defaultv2

Directional: count only breaks toward the other party Why do scores change?

How the House breaks down

5Swing 70–100
59Middle 30–70
363Entrenched 0–30
6Insufficient data not ranked

Members fall into . 6 representatives don’t have enough data yet and are marked “insufficient data”. Non-voting delegates are not counted. The bill is not before the House right now; these scores show where members would stand.

Key players in the House

Ranked by swing score, 0–100 · swing-v3, directional

: only movement toward the other party counts, so members who sit further from the center than their party no longer score as swing votes.

Bars show each input from 0 to 100: ideology gap, scorecard gap, , and the . is the seat’s partisan lean, and shows how much of the input data a score has.

Similar past votes, House

Earlier behind swing-v3’s input

Cosponsors

313 active

Show all 313 cosponsors

Dan Crenshaw (R-TX-2)
Debbie Dingell (D-MI-6)
Diana Harshbarger (R-TN-1)
Doris O. Matsui (D-CA-7)
Gus M. Bilirakis (R-FL-12)
Kathy Castor (D-FL-14)
Kim Schrier (D-WA-8)
Lori Trahan (D-MA-3)
Mike Kelly (R-PA-16)
Randy K. Sr. Weber (R-TX-14)
Ben Cline (R-VA-6)
Carlos A. Gimenez (R-FL-28)
Carol D. Miller (R-WV-1)
Clay Higgins (R-LA-3)
Darren Soto (D-FL-9)
Debbie Wasserman Schultz (D-FL-25)
Ed Case (D-HI-1)
Eleanor Holmes Norton (D-DC-AL)
Gabe Evans (R-CO-8)
Joaquin Castro

How the swing score works

Ideology gapHow far a member’s DW-NOMINATE voting score sits from their party’s median in the same chamber.

Scorecard gapHow far their Heritage Action and LCV ratings stray from their party’s average, using the groups’ votes on similar bills where available.

Cross-pressureHow strongly their district or state leans toward the other party, from our own computed partisan lean.

Similar votesHow often they voted against their own party on earlier roll calls about this bill or similar ones.

Committee bonusMembers of the committees handling the bill decide whether it moves, so they get a boost.

Cosponsor checkThe sponsor and active cosponsors have already committed, so they drop toward entrenched.

1
Jared F. GoldenDemocrat · Maine 2nd · Lean R+4On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 25% of 17 similar votes
95Swing
ContactCall 202-225-6306 Website
2
David P. JoyceRepublican · Ohio 14th · Lean R+9On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 10% of 17 similar votes
82Swing
ContactCall 202-225-5731 Website
3
John JamesRepublican · Michigan 10th · Lean R+3House Committee on Energy and CommerceOn the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
Committee
Broke with party on 8% of 16 similar votes
80Swing
ContactCall
4
Patrick RyanDemocrat · New York 18th · Lean D+2On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 8% of 17 similar votes
74Swing
ContactCall 202-225-5614 Website
5
Steven HorsfordDemocrat · Nevada 4th · Lean D+2On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 7% of 17 similar votes
73Swing
ContactCall 202-225-9894 Website
6
Harold RogersRepublican · Kentucky 5th · Lean R+32On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 8% of 16 similar votes
70Middle
7
Brett GuthrieRepublican · Kentucky 2nd · Lean R+20House Committee on Energy and Commerce (Chair)On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
Committee
Broke with party on 4% of 17 similar votes
68Middle
8
Frank D. LucasRepublican · Oklahoma 3rd · Lean R+23On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 8% of 17 similar votes
68Middle
9
Celeste MaloyRepublican · Utah 2nd · Lean R+10On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 4% of 9 similar votes
66Middle
10
J. French HillRepublican · Arkansas 2nd · Lean R+8On the ballot
Ideology gap
Scorecard gap
Cross-pressure
Similar votes
CommitteeNo committee seatBroke with party on 4% of 17 similar votes
65Middle